Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Blueprint, Dialectic, Exicure, Exithera, Idorsia, Junshi, Kempharm, Oblato, On Target, RDIF, Saniona, Sorrento, Wellmarker, Xentria.